Venous thromboembolic prophylaxis in orthopedic surgery: Knee surgery

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue SUPPL. 3, 1999, Pages 73-77

  Planés, Andre ^a,b   Vochelle, Nicole ^a   Fafola, Michel ^a  

^a Clinique Radio Chirurgicale du Mail   (France)

^b Clinique Radio Chirurgicale du Mail   (France)

Author keywords

Deep vein thrombosis; Knee replacement surgery; Low molecular weight heparin; Venous thromboembolism

Indexed keywords

ARDEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; TINZAPARIN; WARFARIN;

BIOEQUIVALENCE; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; KNEE SURGERY; META ANALYSIS; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; PROPHYLAXIS; VEIN THROMBOSIS;

ANIMALS; EMBOLISM; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; KNEE; ORTHOPEDICS; VENOUS THROMBOSIS;

EID: 0032701735     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cohen SH, Ehrlich GE, Kauffman MS, Cope C. Thrombophlebitis following knee surgery. J Bone Joint Surg Am 1973;55A: 106-112
2. Stulberg BN, Insall JN, Williams GW, Ghelman B. Deep-vein thrombosis following total knee replacement: An analysis of 638 arthroplasties. J Bone Joint Surg Am 1984;66A:194-201
3. Lynch AF, Bourne RB, Rorabeck CH, Rankin RN, Donald A. Deep-vein thrombosis and continuous passive motion after total knee arthroplasty. J Bone Joint Surg Am 1988;70A: 11-14
4. Stringer MD, Steadman CA, Hedges AR, et al. Deep-vein thrombosis after elective knee surgery. An incidence study in 312 patients. J Bone Joint Surg Br 1989;71B:492-197
5. Clagelt GP, Anderson FA, Heit J, Levine MN, Wheeler HB. Prevention of venous thromboembolism. Chest 1995;108:312S-334S
6. Turner RS, Griffiths H, Heatley FW. The incidence of deep-vein thrombosis after upper tibial osteotomy. A venographic study. J Bone Joint Surg Br 1993;75B:942-944
7. Eriksson BI, Kalebo P, Anthymyr BA, et al. Prevention of deep vein thrombosis and pulmonary embolism after total hip replacement. J Bone Joint Surg Am 1991;73A:484-193
8. Maynard MJ, Sculco TP, Ghelman B. Progression and regression of deep vein thrombosis after total knee arthroplasty. Clin Orthop 1991:273:125-130
9. White RH, Romano PS, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998:158:1525-1531
10. McNally MA, Bahadur R, Cooke EA, Mollan RAB. Venous haemodynamics in both legs after total knee replacement. J Bone Joint Surg Br 1997;79B:633-637
11. Hull RD, Pineo GF, Valentine KA. Treatment and prevention of venous thromboembolism. Semin Thromb Hemost 1998;24 (Suppl 1):21-31
12. Howard AW, Aaron SD. Low molecular weight heparin decreases proximal and distal deep venous thrombosis following total knee arthroplasty. A meta-analysis of randomized trials. Thromb Haemost 1998;79:902-906
13. Leclerc JR, Geerts WH, Desjardins L, et al. Prevention of deep vein thrombosis after major knee surgery-a randomized, doubleblind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo. Thromb Haemost 1992;67:417-423
14. Fauno P, Suomalainen O, Rehnberg V, et al. Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. A comparison between unfractionated and low-molecular-weight heparin. J Bone Joint Surg Am 1994;76A: 1814-1818
15. Colwell CW Jr, Spiro TE, Trowbridge AA, et al. for the Enoxaparin Clinical Trial Group. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Clin Orthop 1995:321:19-27
16. Fitzgerald RH Jr. Preventing DVT following total knee replacement: A review of recent clinical trials. Orthopedics 1995;18 (Suppl): 10-11
17. Leclerc JR, Geerts WH, Desjardins L, et al. Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin. Ann Intern Med 1996:124:619-626
18. RD Heparin Arthroplasty Group. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. J Bone Joint Surg Am 1994;76A:1174-1185
19. Levine MN, Gent M, Hirsh J, et al. Ardcparin (low molecular weight heparin) vs. graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery. Arch Intern Med 1996;156: 851-856
20. Heit JA, Berkowitz SD, Bona R, et al. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: A double-blind, dose-ranging study. Thromb Haemost 1997;77:32-38
21. Hull R, Raskob G, Pineo G, et al. A comparison of subcutaneous low molecular weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993:329:1370-1376
22. Hamulyak K, Lensing AWA, van der Meer J, et al. for the Fraxiparin Oral Anticoagulant Study Group. Subcutaneous low molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement. Thromb Haemost 1995;74:1428-1431
23. Bergqvist D. Low molecular weight heparins. J Intern Med 1996;240:63-72
24. Fareed J, Hoppensteadt D, Jeske W, Clarizio R, Walenga JM. Low molecular weight heparins: Are they different? Can J Cardiol 1998;14:28E-34E
25. Enoxaparin Clinical Trial Group. A double-blind multicenter clinical trial comparing long-term enoxaparin and placebo treatments in the prevention of venous thromboembolic disease after hip and knee replacement surgery. Presented at the American Society of Hematology, San Diego, December 1997